This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Risperidone for the Treatment of Monosymptomatic Hypochondriacal Psychosis

Mesut Cetin, Servet Ebrinc, Mehmet Yucel Agargun, and Suat Yigt

Published: August 1, 1999

Article Abstract

Letter to the Editor

Sir: Risperidone is a novel antipsychotic agent that blocks the dopamine (e.g., D2) as well as the serotonin (e.g., 5-HT2) families of receptors. We report a case of monosymptomatic hypochondriacal psychosis that responded to risperidone.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Insights

LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...

Read More...